mRNA疫苗改变了个性化的肺癌治疗方法
Kaiqi Wei1, Zitong Wan1,2,3, Miaomiao Wen1
1Department of Thoracic Surgery, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.
Frontiers in immunology
|March 2, 2026
概括
使者RNA (mRNA) 疫苗在肺癌治疗方面表现有前途,尽管面临当前的挑战,但与传统疫苗相比,它具有优势. 个性化mRNA疫苗正在研究精密瘤学,以改善结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 针对性治疗和免疫治疗在肺癌中面临挑战,原因是获得的耐药性和免疫异质性.
- 晚期肺癌中高瘤突变负担有助于基因组不稳定性和治疗耐药性.
- 传统的癌症疫苗在安全性,个性化和生产方面存在局限性.
研究的目的:
- 审查目前肺癌疫苗的现状.
- 澄清mRNA疫苗对传统方式的治疗优势.
- 突出挑战并提出针对肺癌个性化mRNA疫苗开发的策略.
主要方法:
- 关于肺癌疫苗的当前研究的文献综述.
- 对mRNA疫苗与传统疫苗类型的比较分析.
- 目前正在进行的mRNA肺癌疫苗临床试验概述.
主要成果:
- mRNA疫苗提供高效的免疫反应,低副作用和成本效益.
- mRNA疫苗有可能向多个抗原并重塑瘤免疫微环境.
- 个性化mRNA疫苗是肺癌精密瘤学中的一个有希望的途径.
结论:
- mRNA疫苗代表了肺癌治疗的重大进展.
- 解决安全性,个性化和生产方面的挑战对于mRNA疫苗的成功至关重要.
- 需要基于证据的策略来合理设计和临床应用个性化的mRNA肺癌疫苗.
更多相关视频
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
18.8K
08:14MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
16.3K
相关概念视频
Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Cancer Vaccines
1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Cancer
55.1K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.1K
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Rous Sarcoma Virus (RSV) and Cancer
6.5K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.5K
